Trinity Biotech Plc (TRIB)

Trinity Biotech (TRIB) Financial Statements


Trinity Biotech Financial Overview

Trinity Biotech's market cap is currently ―. The company's EPS TTM is $-0.937; its P/E ratio is -0.78; Trinity Biotech is scheduled to report earnings on October 3, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue-$ 19.50M$ 18.46M$ 18.78M$ 19.52M
Gross Profit-$ 2.02M$ 6.53M$ 7.27M$ 7.24M
EBIT-$ -6.76M$ -1.43M$ 173.00K$ -5.91M
EBITDA-$ -6.01M$ -1.17M$ 173.00K$ -5.91M
Net Income Common Stockholders-$ -8.95M$ -9.71M$ -12.28M$ -1.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.58M$ 7.25M$ 10.45M$ 10.01M$ 25.91M
Total Assets$ 92.10M$ 97.89M$ 107.14M$ 106.10M$ 118.89M
Total Debt$ 44.30M$ 57.91M$ 59.39M$ 76.46M$ 99.16M
Net Debt$ 37.72M$ 50.66M$ 48.94M$ 66.44M$ 73.25M
Total Liabilities$ 90.55M$ 91.26M$ 91.32M$ 112.38M$ 119.21M
Stockholders Equity$ -5.16M$ 6.63M$ 15.82M$ -6.29M$ -319.00K
Cash Flow-
Free Cash Flow-$ -648.00K$ -3.73M$ -6.87M$ 4.17M
Operating Cash Flow-$ 676.00K$ -1.93M$ -4.38M$ 4.40M
Investing Cash Flow-$ -1.32M$ -1.80M$ -2.48M$ -236.00K
Financing Cash Flow-$ -2.37M$ 4.33M$ -9.03M$ -5.79M
Currency in USD

Trinity Biotech Earnings and Revenue History

Trinity Biotech Debt to Assets

Trinity Biotech Cash Flow

Trinity Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis